A Saudi innovation redefining root canal therapy — the world's first ultrasonic obturation system, born from university research and brought to clinical reality.
A new paradigm for root canal therapy — clinically validated and patent-protected across multiple jurisdictions.
A less invasive approach engineered for better seals, greater comfort, and lasting clinical outcomes.
Reaches areas that traditional obturation methods cannot access.
Reduces chair time and post-treatment discomfort.
Eliminates microleakage for better long-term outcomes.
A less invasive approach that maintains tooth integrity.
Validated through years of meticulous research and comprehensive laboratory testing.
Reduction in voids compared to conventional techniques (ex-vivo micro-CT studies).
Thermal profiling confirmed safe temperatures during ultrasonic activation.
Demonstrated adaptation into lateral canals without compromising tooth structure.
Our innovation is secured by international patents across multiple jurisdictions.
Founded by Dr. Mohammed Alshehri and, EndoWeld bridges academic innovation with industrial expertise.
Our mission aligns with Saudi Vision 2030 — localizing advanced medical device manufacturing and positioning the Kingdom as a regional hub for dental technology.
With headquarters in Riyadh, we combine strong intellectual property, clinical validation, and precision manufacturing to bring ultrasonic obturation to dentists worldwide.
Clinical trials and regulatory preparations are underway for the first production run. We welcome collaborations with clinicians, regulators, and distribution partners.
Get in Touch →